Selah Genomics is a personalized medicine diagnostic specialist that was founded in 2012. The company provides advanced molecular and genomic diagnostic services to support healthcare providers and the pharmaceutical industry. It offers a growing portfolio of advanced diagnostic tests, primarily focusing on oncology and infectious disease. Selah Genomics' services are designed to enhance early stage drug development, clinical trials, and regulatory processes in the pharmaceutical industry. These services also assist clinicians and healthcare providers in treating and monitoring patients, thereby improving patient outcomes.
In March 2016, Selah Genomics received a $450.00K debt financing investment. The company is based in the United States and operates within the biotechnology and healthcare sectors.
Taxonomy:
personalized medicine, diagnostic services, genomic testing, oncology, infectious disease, drug development, clinical trials, regulatory processes, pharmaceutical industry, patient outcomes, genomic diagnostics, molecular diagnostics, healthcare providers